Target Acquisition

Bill passed: wide range of psychedelics could be made legal in the US

Finfeed Archived Jun 03, 2021

In what is a major development for Creso Pharma (ASX: CPH), target acquisition company Halucencex Life Sciences is fast tracking its go to market strategy in California. This follows the recent passing of Senate Bill 519 through the California State Senate, which if signed into law, would make a wide range of psychedelic substances including psilocybin legal to use and possess for adults over the age of 21.

CPH further derisks acquisition as Halucenex adds to its psychedelics supply

Finfeed Archived May 14, 2021

Creso Pharma Limited (ASX: CPH, FRA:1X8) target acquisition company Halucenex Life Sciences has nearly doubled its supply of synthetic psilocybin. Halucenex has secured an additional 10 grams of synthetic psilocybin from its manufacturing partner – Canada’s only pharmaceutical grade synthetic psilocybin producer.